FDA Inspection
Alexion Pharmaceuticals, Inc.Alexion Pharmaceuticals, Inc. – FDA Inspection, Jul 21, 2017
Record Details
This FDA Inspection record concerns Alexion Pharmaceuticals, Inc., with an inspection on July 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 98141ff0-1eb5-4854-b322-21be7b525527
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1019062
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Alexion Pharmaceuticals, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 12, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 22, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alexion Pharmaceuticals, Inc.
- FDA Inspection 984855 - 2016-08-03
- FDA Inspection 938440 - 2015-08-12
- FDA Inspection 892913 - 2014-08-22
- FDA Inspection 710477 - 2011-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.